Gubra A/S (GUBRF)
OTCMKTS · Delayed Price · Currency is USD
60.15
-38.54 (-39.05%)
At close: May 6, 2025

Revenue by Product

Fiscal year is January - December.
Year Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Pre-clinical Contract Research
220.22M
Log In
Log In
Log In
Log In
Pre-clinical Contract Research Growth
30.65%
Log In
Log In
Log In
Log In
Discovery and Partnership
45.52M
Log In
Log In
Log In
Log In
Discovery and Partnership Growth
24.90%
Log In
Log In
Log In
Log In

Revenue by Geography

Fiscal year is January - December.
Year Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
United States
101.00M
Log In
Log In
Log In
Log In
United States Growth
17.44%
Log In
Log In
Log In
Log In
Europe
65.63M
Log In
Log In
Log In
Log In
Europe Growth
109.84%
Log In
Log In
Log In
Log In
Germany
49.00M
Log In
Log In
Log In
Log In
Germany Growth
11.36%
Log In
Log In
Log In
Log In
Denmark
43.00M
Log In
Log In
Log In
Log In
Denmark Growth
30.30%
Log In
Log In
Log In
Log In
North America
204.00K
Log In
Log In
Log In
Log In
North America Growth
-92.67%
Log In
Log In
Log In
Log In
Other
6.91M
Log In
Log In
Log In
Log In
Other Growth
-13.10%
Log In
Log In
Log In
Log In